1. Home
  2. FEMY vs ELOG Comparison

FEMY vs ELOG Comparison

Compare FEMY & ELOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

SELL

Current Price

$1.22

Market Cap

11.5M

Sector

Health Care

ML Signal

SELL

Logo Eastern International Ltd. Ordinary Shares

ELOG

Eastern International Ltd. Ordinary Shares

SELL

Current Price

$1.83

Market Cap

11.7M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
FEMY
ELOG
Founded
2004
2006
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Integrated Freight & Logistics
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
11.7M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
FEMY
ELOG
Price
$1.22
$1.83
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $14.75
N/A
AVG Volume (30 Days)
104.8K
★ 250.8K
Earning Date
11-13-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 44.71
N/A
EPS
N/A
★ N/A
Revenue
★ $2,293,313.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$294.61
N/A
P/E Ratio
★ N/A
$6.84
Revenue Growth
★ 40.77
N/A
52 Week Low
$0.29
$0.40
52 Week High
$6.29
$2.83

Technical Indicators

Market Signals
Indicator
FEMY
ELOG
Relative Strength Index (RSI) 36.99 78.34
Support Level $0.33 $0.81
Resistance Level $1.55 N/A
Average True Range (ATR) 0.14 0.19
MACD 0.01 0.10
Stochastic Oscillator 36.46 93.92

Price Performance

Historical Comparison
FEMY
ELOG

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products.

Share on Social Networks: